Targets › LAMB3
1 program from 1 company in 1 trial: 1 Phase 1; Other.
Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. (UniProt, Q13751)
Open in Phaseline: the race on LAMB3, likelihood bands and readouts
| Company | Drug | Targets | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|---|
| University of Southern California | Gentamicin Bacterial 70S ribosome inhibitor | LAMB3, LAMA3, LAMC2 | Phase 1 | Junctional Epidermolysis Bullosa | – |
Junctional Epidermolysis Bullosa (1)
small molecule (1)
Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.